Clinical Significance of Detection of Serum High-sensitivity C-reactive Protein in Patients with Gestational Diabetes Mellitus

Hu Shao
2009-01-01
Abstract:Objective To explore the clinical significance of detecting serum high-sensitivity C-reactive protein (hs-CRP) levels in patients with gestational diabetes mellitus (GDM). Methods Fifty-one patients with GDM and 45 pregnant women with normal glucose tolerance (NGT) were observed. ELISA was used to evaluate serum hs-CRP level. Fasting plasma glucose (FPG) and fasting insulin (FIns) were measured by oxidized assay and immunoradioassay. Insulin resistance index (HOMA-IR) was calculated. Results The levels of FPG,FIns,HOMA-IR and hs-CRP in GDM group [(6.09±0.79)mmol/L,(17.03±7.58)mIU/L,(3.88±2.01),and (11.07±3.69)mg/L] were significantly higher than those of normal group [(4.30±0.50)mmol/L,(13.39±3.17)mIU/L,(2.59±0.69),and (6.08±2.54)mg/L](P0.01). Circulation level of hs-CRP was correlated with HOMA-IR (r=0.288,P0.01),FIns(r=0.301,P0.01),and BMI(r=0.196,P0.01). Conclusions The data support the hypothesis that low-grade systemic inflammation is closely related to insulin resistance. hs-CRP is a strong predictor for the development of GDM.
What problem does this paper attempt to address?